 |
|
Strategic application of radiotherapy for hepatocellular carcinoma
Seo Hee Choi, Jinsil Seong
Clin Mol Hepatol. 2018;24(2):114-134. Published online 2018 Feb 14 DOI: https://doi.org/10.3350/cmh.2017.0073
|
|
Citations to this article as recorded by
 Lenvatinib Synergistically Promotes Radiation Therapy in Hepatocellular Carcinoma by Inhibiting Src/STAT3/NF-κB-Mediated Epithelial–Mesenchymal Transition and Metastasis
Yueh-Shan Weng, I-Tsang Chiang, Jai-Jen Tsai, Yu-Chang Liu, Fei-Ting Hsu
International Journal of Radiation Oncology*Biology*Physics.2023; 115(3): 719. CrossRef 2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Journal of Liver Cancer.2023; 23(1): 1. CrossRef Radionuclide‐Labeled Microspheres for Radio‐Immunotherapy of Hepatocellular Carcinoma
Sai Yang, Chongjing Mu, Teng Liu, Pei Pei, Wenhao Shen, Yanxiang Zhang, Guanglin Wang, Lei Chen, Kai Yang
Advanced Healthcare Materials.2023;[Epub] CrossRef Advances in radiotherapy and immunity in hepatocellular carcinoma
Yuhan Yang, Liting Xiong, Mengyuan Li, Ping Jiang, Junjie Wang, Chunxiao Li
Journal of Translational Medicine.2023;[Epub] CrossRef Attenuated Salmonella carrying siRNA-PD-L1 and radiation combinatorial therapy induces tumor regression on HCC through T cell-mediated immuno-enhancement
Huijie Jia, Pengkun Wei, Shijie Zhou, Yuanyuan Hu, Chunjing Zhang, Lirui Liang, Bingqing Li, Zerui Gan, Yuanling Xia, Hanyu Jiang, Mingguang Shao, Sheng Guo, Zishan Yang, Jiateng Zhong, Feng Ren, Huiyong Zhang, Yongxi Zhang, Tiesuo Zhao
Cell Death Discovery.2023;[Epub] CrossRef Carbon Ion Radiotherapy in the Treatment of Hepatocellular Carcinoma
Hwa Kyung Byun, Changhwan Kim, Jinsil Seong
Clinical and Molecular Hepatology.2023; 29(4): 945. CrossRef Impact of Intrahepatic External Beam Radiotherapy in Advanced Hepatocellular Carcinoma Patients Treated with Tyrosine Kinase Inhibitors
Myung Ji Goh, Hee Chul Park, Jeong Il Yu, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Dong Hyun Sinn, Moon Seok Choi
Liver Cancer.2023; 12(5): 467. CrossRef Large hepatocellular carcinoma treated with sequential SBRT and immunotherapy with anti-VEGF (Vascular Endothelial Growth Factor) therapy
Bardia Bidarmaghz, Marwan Idrees, Yoo Young Lee, Peter Hodgkinson
BMJ Case Reports.2023; 16(12): e256931. CrossRef MiR-122 radiosensitize hepatocellular carcinoma cells by suppressing cyclin G1
Gang Xu, Shanshan Bu, Xiushen Wang, Hong Ge
International Journal of Radiation Biology.2022; 98(1): 11. CrossRef Liver-Directed Concurrent Chemoradiotherapy versus Sorafenib in Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis
Jina Kim, Hwa Kyung Byun, Tae Hyung Kim, Sun Il Kim, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Do Young Kim, Jinsil Seong
Cancers.2022; 14(10): 2396. CrossRef Efficacy and safety of radiotherapy plus anti-PD1 versus transcatheter arterial chemoembolization plus sorafenib for advanced hepatocellular carcinoma: a real-world study
Jian-Xu Li, Wen-Xiang Deng, Shi-Ting Huang, Xiao-Feng Lin, Mei-Ying Long, Jie Zhang, Ting-Shi Su, Li-Qing Li, Ya-Dan Pang, Chun-Feng Liang, Hong-Mei Zhou, Hai-Yan Lu, Shi-Xiong Liang, Bang-De Xiang
Radiation Oncology.2022;[Epub] CrossRef The α-RECIST (RECIST 1.1 Combined With Alpha Fetoprotein): A Novel Tool for Identifying Tumor Response of Conversion-Radiotherapy for Unresectable Hepatocellular Carcinoma Before Hepatectomy
Ying Xu, Yi Yang, Lu Li, Feng Ye, Xinming Zhao
Frontiers in Oncology.2022;[Epub] CrossRef 2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Clinical and Molecular Hepatology.2022; 28(4): 583. CrossRef 2022 KLCA-NCC Korea Practice Guidelines for the Management of Hepatocellular Carcinoma
Korean Journal of Radiology.2022; 23(12): 1126. CrossRef External radiotherapy combined with sorafenib has better efficacy in unresectable hepatocellular carcinoma: a systematic review and meta-analysis
Han Li, Zhenying Wu, Jiali Chen, Ke Su, Lu Guo, Ke Xu, Tao Gu, Yi Jiang, Pan Wang, Hao Zeng, Hao Chi, Kun He, Yunwei Han
Clinical and Experimental Medicine.2022; 23(5): 1537. CrossRef Dose-Response Relationship in Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: A Pooled Analysis of an Asian Liver Radiation Therapy Group Study
Nalee Kim, Jason Cheng, Wen-Yen Huang, Tomoki Kimura, Zhao Chong Zeng, Victor H.F. Lee, Chul Seung Kay, Jinsil Seong
International Journal of Radiation Oncology*Biology*Physics.2021; 109(2): 464. CrossRef Optimal Timing of Radiotherapy after Incomplete Transarterial Chemoembolization for Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma
Hwa Kyung Byun, Nalee Kim, Jinsil Seong
Yonsei Medical Journal.2021; 62(5): 409. CrossRef PKI-587 enhances radiosensitization of hepatocellular carcinoma by inhibiting the PI3K/AKT/mTOR pathways and DNA damage repair
Yinghai Xie, Changwei Liu, Yinci Zhang, Amin Li, Chong Sun, Rui Li, Yingru Xing, Minghong Shi, Qi Wang, Yi-Hsien Hsieh
PLOS ONE.2021; 16(10): e0258817. CrossRef Lupeol-Loaded Nanoparticles Enhance the Radiosensitivity of Hepatocellular Carcinoma by Inhibiting the Hyperactivation in Raf/Mitogen-Activated Protein Kinase and Phospatidylinositol-3 Kinase/mTOR Pathways
Yinghai Xie, Changwei Liu, Shuping Zhou, Qi Wang, Xiaolong Tang
Journal of Biomedical Nanotechnology.2021; 17(11): 2247. CrossRef CT‐guided liver beacon transponder implantation
Yufeng Zhang, Xia He, Wenjie Guo, Li Sun, Chang Guo, Yong Feng
Precision Medical Sciences.2021; 10(1): 42. CrossRef Treatment efficacy by hepatic arterial infusion chemotherapy vs. sorafenib after liver-directed concurrent chemoradiotherapy for advanced hepatocellular carcinoma
Sojung Han, Hye Jin Choi, Seung-Hoon Beom, Hye Rim Kim, Hyein Lee, Jae Seung Lee, Hye Won Lee, Jun Yong Park, Seung Up Kim, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Jinsil Seong, Jong Yun Won, Beom Kyung Kim
Journal of Cancer Research and Clinical Oncology.2021; 147(10): 3123. CrossRef Novel approaches to intervene gut microbiota in the treatment of chronic liver diseases
Chang Liu, Yu‐Li Wang, Yong‐Yu Yang, Ning‐Ping Zhang, Chen Niu, Xi‐Zhong Shen, Jian Wu
The FASEB Journal.2021;[Epub] CrossRef MR-Guided Radiotherapy for Liver Malignancies
Luca Boldrini, Stefanie Corradini, Cihan Gani, Lauren Henke, Ali Hosni, Angela Romano, Laura Dawson
Frontiers in Oncology.2021;[Epub] CrossRef ATF2-Induced Overexpression of lncRNA LINC00882, as a Novel Therapeutic Target, Accelerates Hepatocellular Carcinoma Progression via Sponging miR-214-3p to Upregulate CENPM
Hua Ren, Zhi-cheng Wei, Yan-xia Sun, Chun-yan Qiu, Wen-jue Zhang, Wei Zhang, Tao Liu, Xu Che
Frontiers in Oncology.2021;[Epub] CrossRef KIF2C promotes the proliferation of hepatocellular carcinoma cells in vitro and in vivo
Zhenya Gao, Huanxia Jia, Fang Yu, Hongfang Guo, Baoyu Li
Experimental and Therapeutic Medicine.2021;[Epub] CrossRef Silencing the Expression of Cyclin G1 Enhances the Radiosensitivity of Hepatocellular Carcinoma In Vitro and In Vivo by Inducing Apoptosis
Gang Xu, Shanshan Bu, Xiushen Wang, Hong Ge
Radiation Research.2021;[Epub] CrossRef Delayed response to proton beam treatment of hepatocellular carcinoma
Chee-Wai Cheng, Mitchell Machtay, Jennifer Dorth, Olga Sergeeva, Hangsheng Xia, chawan manaspon, Hanping wu, Renuka Iyer, Sandra Sexton, Wei Xin, Agata A Exner, Zhenghong Lee
BJR|case reports.2020; 6(1): 20180125. CrossRef Stereotactic body radiation therapy vs. radiofrequency ablation in Asian patients with hepatocellular carcinoma
Nalee Kim, Jason Cheng, Inkyung Jung, Ja Der Liang, Yu Lueng Shih, Wen-Yen Huang, Tomoki Kimura, Victor H.F. Lee, Zhao Chong Zeng, Ren Zhenggan, Chul Seung Kay, Seok Jae Heo, Jong Yoon Won, Jinsil Seong
Journal of Hepatology.2020; 73(1): 121. CrossRef Circular RNA TUBD1 Acts as the miR-146a-5p Sponge to Affect the Viability and Pro-Inflammatory Cytokine Production of LX-2 Cells through the TLR4 Pathway
Hao Niu, Li Zhang, Yu-Han Chen, Bao-Ying Yuan, Zhi-Feng Wu, Jason Chia-Hsien Cheng, Qin Lin, Zhao-Chong Zeng
Radiation Research.2020; 193(4): 383. CrossRef Prognosis of Early-Stage Hepatocellular Carcinoma: Comparison between Trans-Arterial Chemoembolization and Radiofrequency Ablation
Byung-Yoon Yun, Hye Won Lee, In Kyung Min, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim
Cancers.2020; 12(9): 2527. CrossRef Huge Hepatocellular Carcinoma Exhibiting a Complete Response after Stereotactic Body Radiation Therapy
Kyung In Shin, Byoung Kuk Jang, Jin Hee Kim, Jae Seok Hwang
Journal of Liver Cancer.2020; 20(2): 167. CrossRef Hepatocellular Carcinoma in Korea between 2012 and 2014: an Analysis of Data from the Korean Nationwide Cancer Registry
Young Eun Chon, Han Ah Lee, Jun Sik Yoon, Jun Yong Park, Bo Hyun Kim, In Joon Lee, Suk Kyun Hong, Dong Hyeon Lee, Hyun-Joo Kong, Eunyang Kim, Young-Joo Won, Jeong-Hoon Lee
Journal of Liver Cancer.2020; 20(2): 135. CrossRef External beam radiation therapy in a centenarian with primary liver cancer
Zhen Meng, Feifei Gao, Chang Liu, Shengcai Huang, Kai Hu, Rensheng Wang
Medicine.2020; 99(47): e22473. CrossRef Acute severe lymphopenia by radiotherapy is associated with reduced overall survival in hepatocellular carcinoma
Hwa Kyung Byun, Nalee Kim, Sangjoon Park, Jinsil Seong
Strahlentherapie und Onkologie.2019; 195(11): 1007. CrossRef Development and validation of a prognostic model for patients with hepatocellular carcinoma undergoing radiofrequency ablation
Chang Gon Kim, Hyun Woong Lee, Hye Jin Choi, Jung Il Lee, Hye Won Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang‐Hyub Han, Han Sang Kim, Kyung Hwan Kim, Seong Jin Choi, Yongun Kim, Kwan Sik Lee, Gyoung Min Kim, Man Deuk Kim, Jong Yoo
Cancer Medicine.2019; 8(11): 5023. CrossRef Combined transarterial chemoembolization and radiotherapy as a first-line treatment for hepatocellular carcinoma with macroscopic vascular invasion: Necessity to subclassify Barcelona Clinic Liver Cancer stage C
Yeon Joo Kim, Jinhong Jung, Ji Hyeon Joo, So Yeon Kim, Jin Hyoung Kim, Young-Suk Lim, Han Chu Lee, Jong Hoon Kim, Sang Min Yoon
Radiotherapy and Oncology.2019; 141: 95. CrossRef Radiation-induced Myositis after Proton Beam Therapy to Huge Hepatocellular Carcinoma
Jihye Kim, Gyu Sang Yoo, Dong Hyun Sinn, Hee Chul Park, Kwang Cheol Koh
Journal of Liver Cancer.2019; 19(2): 136. CrossRef Changes in real-life practice for hepatocellular carcinoma patients in the Republic of Korea over a 12-year period: A nationwide random sample study
Beom Kyung Kim, Do Young Kim, Kwang-Hyub Han, Jinsil Seong, Jung Weon Lee
PLOS ONE.2019; 14(10): e0223678. CrossRef Knockdown of interferon‑stimulated gene 15 affects the sensitivity of hepatocellular carcinoma cells to norcantharidin
Baoxiang Chen, Shuqiang Jin, Bin Bai, Zhi Li, Caifang Ni, Yansen Liu
Experimental and Therapeutic Medicine.2019;[Epub] CrossRef Novel thioureido-benzenesulfonamide derivatives with enaminone linker as potent anticancer, radiosensitizers and VEGFR2 inhibitors
Mostafa M. Ghorab, Fatma A. Ragab, Helmy I. Heiba, Marwa G. El-Gazzar, Mostafa G.M. El-Gazzar
Bioorganic & Medicinal Chemistry Letters.2018; 28(9): 1464. CrossRef Proton beam therapy in apneic oxygenation treatment of an unresectable hepatocellular carcinoma: A case report and review of literature
Yi-Lan Lin
World Journal of Hepatology.2018; 10(10): 772. CrossRef
|